At a glance
- Originator Eli Lilly
- Mechanism of Action Opioid kappa receptor antagonists; Opioid mu receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Heroin abuse
Most Recent Events
- 22 Oct 1999 New profile
- 22 Oct 1999 Preclinical development for Heroin abuse in USA (Unknown route)